查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1521027

輸液袋市場 – 2024 年至 2029 年預測

IV Bags Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計輸液袋市場在預測期內將以 6.13% 的年複合成長率(CAGR)成長，並從 2024 年的估計值40.61 億美元增加到 2029 年達到 54.67 億美元。

機動車事故是全球殘疾和死亡的主要原因之一，每年造成 5,000 萬人受傷、130 萬人死亡。據世界衛生組織 (WHO) 稱，全球整體四分之一的死亡與步行或騎自行車有關。因此，越來越多的手術和事故將需要靜脈輸液，這預計將刺激市場擴張。

慢性病盛行率的增加和老年人口的增加對市場動態產生了重大影響。此外，該地區不斷成長的醫療保健支出和嚴格的患者安全監管政策預計將在預測期內增加對廚房設備的需求。然而，由於手術治療的預期增加，預計市場將穩定上漲。

慢性病盛行率的增加預計將推動市場成長。

慢性病盛行率上升、手術和道路事故數量增加以及老年人口增加等因素預計將在預測期內推動市場成長。輸液袋市場需求的主要促進因素是癌症、神經系統疾病和胃腸道疾病等慢性病的盛行率上升。

例如，根據美國國立衛生研究院2022年7月的數據，截至2022年，北美和歐洲等西方地區約20%的人將患有胃食道逆流（GERD）。此外，美國的 GERD 優勢從 18.1% 擴大到 27.8%。

此外，《2023 年癌症現實與數字》報告中的資訊預測，到 2023 年，美國將有 297,790 名女性被診斷出乳癌，高於 2022 年的 287,850 名當代病例。此外，據同一資訊來源稱，預計到 2023 年，美國將有約 55,720 名女性被原位診斷出乳癌，而 2022 年這一數字為 51,400 例。由於癌症治療會剝奪身體的營養並導致潰瘍、胃腸功能障礙和身體阻塞，從而影響身體，因此對靜脈輸液袋的需求預計將會增加。接受腸外營養的患者日益成長的需求將推動市場擴張。

醫院部門預計將推動市場成長。

越來越多的醫院管理的需要靜脈注射治療的疾病增加了醫院對靜脈注射袋的需求。慢性病的增加也推動了全球對靜脈注射袋的需求。

隨著癌症手術和器官移植手術的增加，在移植手術期間和之後需要靜脈輸液，靜脈輸液袋預計在未來幾年在醫院領域將會成長。根據衛生資源與服務管理局organdonor.gov統計，截至2024年3月，美國進行了27,332例腎臟移植手術、10,660例肝臟移植手術、102例胰臟移植手術、812例心臟移植手術和4,545例肺移植手術。增加新產品的推出和監管部門的核准也推動了市場的成長。

隨著人口老化和慢性病的盛行率上升，醫院對輸液袋的需求將會增加。此外，不斷增加的產品推出和推廣從全國各地醫院收集的輸液袋的回收也推動了輸液袋市場的發展。

例如，2023 年 12 月，百特國際與芝加哥西北醫學院合作，完成了美國醫院靜脈輸液袋回收計畫試點的初始階段。超過 6 噸的 PVC IV 袋廢棄物從垃圾掩埋場轉入回收再生用。同樣，2023 年 2 月，新加坡大型三級醫院 NUH 發起了新加坡首個輸液袋回收計劃。

預計北美地區市場將成長。

在美國和加拿大等新興經濟體，慢性病的流行預計將提振市場。醫療保健支出的成長趨勢加上人口老化的加劇將對靜脈輸液袋的需求產生重大影響。美國癌症患者數量的增加也反映出靜脈輸液袋需求增加的潛在需求前景。例如，根據美國癌症協會的數據，預計2023年新患者人數將達到1,958,310人，其中男性1,010,310人，女性948,000人，相較之下，同年預計死亡人數達到609,820人。

主要市場發展：

  • 2023 年 2 月，Bowmed Ibisqus 推出了 Ready to Administer IV 左氧氟沙星 500mg/100ml 袋裝。該袋子採用鋁箔外包裝，可避光並顯示產品資訊。新產品已在 AAH 註冊，代碼為 LEV0316T。因此，未來幾年的市場擴張可能會受到醫院對靜脈輸液袋日益依賴的推動。

主要參與者

  • Sippex 是 PVC 和多層袋及連接器的領先製造商。我們專注於醫療袋和連接器的設計和製造，為製藥和醫療解決方案提供創新的軟質包裝，包括靜脈輸液袋和連接器。 SIPPEX 提供高性能機械和 30 年的塑膠加工專業知識。
  • Technoflex 是歐洲領先的輸注藥物輸送袋和連接器設計、製造和商業化公司，並獲得 FDA 和 EMEA 認證。 Technoflex 擁有 40 多年的經驗，與領先的製藥實驗室合作，推出創新技術，改進包裝並使看護者更容易處理注射劑。
  • Metrix 公司是美國醫療設備製造商，產品包括血袋、輸血過濾器、靜脈輸液器、PVC 和 EVA 容器、腔室、雙袋和配件。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章 箱包市場：依材料類型

  • 介紹
  • PVC
  • PP
  • PE

第6章 IV 箱包市場：依容量分類

  • 介紹
  • 小於100毫升
  • 100～250ml
  • 250～500ml
  • 500～1000ml
  • 1000ml以上

第7章 箱包市場：依箱型分類

  • 介紹
  • 單室
  • 多室

第8章 箱包市場：依最終用戶分類

  • 介紹
  • 血庫
  • 醫院
  • 門診服務

第9章 箱包市場：依地區分類

  • 介紹
  • 北美洲
    • 依材料類型
    • 按容量
    • 按腔室類型
    • 按最終用戶
    • 按國家/地區
  • 南美洲
    • 依材料類型
    • 按容量
    • 按腔室類型
    • 按最終用戶
    • 按國家/地區
  • 歐洲
    • 依材料類型
    • 按容量
    • 按腔室類型
    • 按最終用戶
    • 按國家/地區
  • 中東/非洲
    • 依材料類型
    • 按容量
    • 按腔室類型
    • 按最終用戶
    • 按國家/地區
  • 亞太地區
    • 依材料類型
    • 按容量
    • 按腔室類型
    • 按最終用戶
    • 按國家/地區

第10章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第11章 公司簡介

  • Sippex
  • Kraton Corporation
  • Renolit Solmed
  • Alfa Laboratories
  • Polycine GmbH
  • Haemotronic SPA
  • Hospira Inc.
  • Technoflex SA
  • The Metrix Company
  • Medicopack A/S
  • Wipak Group
  • Qosina Corporation
簡介目錄
Product Code: KSI061612706

The IV bags market is anticipated to grow at a compound annual growth rate (CAGR) of 6.13% over the forecast period to reach US$5.467 billion by 2029, increasing from estimated value of US$4.061 billion in 2024.

The supply of plastic materials needed for intravenous therapy with important applications in hospital care defines the global market for IV bags, which has graduated as a key segment within the field of parental packaging. Electrolyte depletion is uncommon in individuals with fever and diarrhea. Lack of hydration, which is more common in children, is too brought on by this and can become serious. Moreover, IV packs are becoming progressively prevalent and favored alternatives for parenteral bundling due to their simple accessibility. The cost of an IV sack is roughly $1, which significantly contributes to the market's rising deals.

Car crashes are one of the leading causes of disability and death worldwide, resulting in up to 50 million injuries and 1.3 million fatalities annually. Across the globe, one in every four deaths is related to walking or bicycling, based on the World Health Organization. Fluid administration is therefore required due to the rising number of surgeries and accidents, which is anticipated to spur market expansion.

Market dynamics have been greatly affected by the growing prevalence of chronic disease and the increasing geriatric population. Furthermore, an increase in healthcare spending in the region and strict regulatory policies for patient safety are expected to increase the kitchen appliance demand in the forecast period. However, with projections of growing surgical treatment, the market is expected to rise steadily.

The increasing prevalence of chronic diseases is anticipated to propel market growth.

Factors such as the rising prevalence of chronic diseases, the increased number of surgeries and road accidents, and the growing geriatric population are expected to drive market growth during the forecast period. The primary driver of the market's demand for IV bags is the rising prevalence of chronic illnesses like cancer, neurological disorders, and gastrointestinal disorders.

For instance, according to the National Institute of Health in July 2022 stated that around 20% of individuals in western locales, such as North America and Europe, have gastroesophageal reflux illness (GERD) as of 2022. Besides, the predominance of GERD in the US extended from 18.1% to 27.8%

Furthermore, information from the Cancer Realities and Figures 2023 report demonstrates that 297,790 ladies in the US are expected to get an obtrusive breast cancer conclusion in 2023, up from 287,850 modern cases in 2022. Additionally, the same source states that in 2023, compared to 51,400 cases in 2022, approximately 55,720 women in the US are anticipated to receive a non-invasive (in situ) breast cancer diagnosis. Since cancer treatment deprives the body of nutrition and affects the body by causing ulcers, gastrointestinal dysfunction, and physical blockages, it is anticipated that the demand for IV bags will increase. It increases the need for patients to receive parenteral nutrition, which drives market expansion.

The hospitals segment is anticipated to propel market growth.

The increase in medical conditions that need hospital administration, which requires IV therapy, has bolstered the demand for IV bags in hospitals. The rise in the prevalence of chronic disease also drives the demand for IV bags globally.

Increasing cancer surgeries as well as organ transplant procedures also demand infusing intravenous fluids both during and after the completion of transplant surgery, which will lead to the growth of IV bags in the hospital sector in the coming years. As per Health Resources & Services Administration, organdonor.gov, the transplant performed by organs in the U.S. of kidney, liver, pancreas, heart, and lungs were 27,332, 10,660, 102, 812, and 4,545 respectively, as of March 2024. Additionally, Increasing launches of new products and approvals from the regulatory bodies also drive the growth of the market.

The demand for IV bags in hospitals will increase with the growing aging population, and rise in the prevalence of chronic diseases. Additionally, rising product launches and recycling drives of IV bags collected from hospitals across the country also drive the market for IV bags.

For instance, in December 2023, Baxter International completed the initial phase of its intravenous bag recycling program pilot for U.S. hospitals, partnering with Northwestern Medicine in Chicago. Over six tons of PVC IV bag waste were diverted from landfills for recycling. Similarly, in February 2023, NUH, a large tertiary hospital in Singapore, initiated Singapore's first IV fluid bag recycling drive.

The market is projected to grow in the North American region.

The growing prevalence of chronic diseases is anticipated to boost the market in developed economies such as the United States and Canada among others. The increasing trend of healthcare spending coupled with the enlargement of the geriatric population will have a significant impact on the demand for IV bags. The rising burden of cancer cases in the United States also reflects potential demand prospects in the growth in demand for IV bags. For instance, as per the American Cancer Society, Inc, the Estimated New Cases in 2023 reached 1,958,310, comprising 1,010,310 for males and around 948,000 for females whereas the Estimated Deaths reached 609,820 in the same year.

Key Market Developments:

  • In February 2023, Bowmed Ibisqus launched a Ready to Administer IV Levofloxacin 500mg/100ml Bag, offering a convenient and efficient dose form. The bag is packaged with a foil overwrap to protect it from light and displays product information. The new product line is listed with AAH under code LEV0316T. Consequently, the market's expansion in the upcoming years will be driven by the increasing reliance on IV bags in hospitals.

Key Players:

  • Sippex is a leading manufacturer of PVC and multilayer bags and connectors. They are specialized in designing and manufacturing medical bags and connectors, offering innovative flexible packaging for pharmaceutical and medical solutions, including IV bags and connectors. SIPPEX offers high-performance machinery and 30 years of expertise in plastic processing. Vertically integrated, the corporation controls all technologies involved in the production process, from raw materials to completed goods.
  • Technoflex is a leading European company in designing, producing, and commercializing I.V. drug delivery bags and connectors, with FDA and EMEA references. With over 40 years of experience, Technoflex has collaborated with major pharmaceutical laboratories and introduced innovations to improve packaging, facilitating caregivers' manipulation of injectable products.
  • The Metrix Company is a US-based manufacturer of medical devices like blood bags, transfusion filters, IV sets, PVC and EVA containers, chambers, dual bags, and accessories.

Segmentation:

By Material Type

  • PVC
  • PP
  • PE

By Capacity

  • Less than 100 ml
  • 100-250 ml
  • 250-500 ml
  • 500-1000 ml
  • Above 1000 ml

By Chamber Type

  • Single Chamber
  • Multi Chamber

By End-User

  • Blood Banks
  • Hospitals
  • Ambulatory Services

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. IV BAGS MARKET BY MATERIAL TYPE

  • 5.1. Introduction
  • 5.2. PVC
  • 5.3. PP
  • 5.4. PE

6. IV BAGS MARKET BY CAPACITY

  • 6.1. Introduction
  • 6.2. Less than 100 ml
  • 6.3. 100-250 ml
  • 6.4. 250-500 ml
  • 6.5. 500-1000 ml
  • 6.6. Above 1000 ml

7. IV BAGS MARKET BY CHAMBER TYPE

  • 7.1. Introduction
  • 7.2. Single Chamber
  • 7.3. Multi Chamber

8. IV BAGS MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Blood Banks
  • 8.3. Hospitals
  • 8.4. Ambulatory Services

9. IV BAGS MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Material Type
    • 9.2.2. By Capacity
    • 9.2.3. By Chamber Type
    • 9.2.4. By End-User
    • 9.2.5. By Country
      • 9.2.5.1. United States
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. South America
    • 9.3.1. By Material Type
    • 9.3.2. By Capacity
    • 9.3.3. By Chamber Type
    • 9.3.4. By End-User
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
      • 9.3.5.2. Argentina
      • 9.3.5.3. Others
  • 9.4. Europe
    • 9.4.1. By Material Type
    • 9.4.2. By Capacity
    • 9.4.3. By Chamber Type
    • 9.4.4. By End-User
    • 9.4.5. By Country
      • 9.4.5.1. Germany
      • 9.4.5.2. United Kingdom
      • 9.4.5.3. France
      • 9.4.5.4. Spain
      • 9.4.5.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. By Material Type
    • 9.5.2. By Capacity
    • 9.5.3. By Chamber Type
    • 9.5.4. By End-User
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
      • 9.5.5.2. UAE
      • 9.5.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. By Material Type
    • 9.6.2. By Capacity
    • 9.6.3. By Chamber Type
    • 9.6.4. By End-User
    • 9.6.5. By Country
      • 9.6.5.1. China
      • 9.6.5.2. Japan
      • 9.6.5.3. South Korea
      • 9.6.5.4. India
      • 9.6.5.5. Thailand
      • 9.6.5.6. Indonesia
      • 9.6.5.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Sippex
  • 11.2. Kraton Corporation
  • 11.3. Renolit Solmed
  • 11.4. Alfa Laboratories
  • 11.5. Polycine GmbH
  • 11.6. Haemotronic S.P.A.
  • 11.7. Hospira Inc.
  • 11.8. Technoflex S.A.
  • 11.9. The Metrix Company
  • 11.10. Medicopack A/S
  • 11.11. Wipak Group
  • 11.12. Qosina Corporation